A detailed history of Silvercrest Asset Management Group LLC transactions in Xencor Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 144,235 shares of XNCR stock, worth $2.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
144,235
Previous 137,941 4.56%
Holding current value
$2.63 Million
Previous $2.93 Million 8.98%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $117,383 - $166,916
6,294 Added 4.56%
144,235 $3.19 Million
Q3 2023

Nov 14, 2023

SELL
$20.08 - $25.39 $7,007 - $8,861
-349 Reduced 0.25%
137,941 $2.78 Million
Q2 2023

Aug 14, 2023

BUY
$24.77 - $29.9 $1.36 Million - $1.64 Million
54,884 Added 65.8%
138,290 $3.45 Million
Q1 2023

May 15, 2023

BUY
$25.95 - $36.95 $2.16 Million - $3.08 Million
83,406 New
83,406 $2.33 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.09B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.